Krishna Jadhav

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Small Cell Lung Cancer

Cognitive Decline

Tyrosine Kinase

Pulmonary Tuberculosis

Top Venues

ACS infectious diseases

Molecular neurobiology

Current drug delivery

Journal of materials chemistry. B

This page only lists publications with an associated author ORCID identifier.

Publications

Krishna Jadhav, Agrim Jhilta, Raghuraj Singh, Eupa Ray, Vimal Kumar, Awadh Bihari Yadav, Amit Kumar Singh, Rahul Kumar Verma
Effective cerebral tuberculosis treatment via nose-to-brain transport of anti-TB drugs using mucoadhesive nano-aggregates. Nanoscale (2024)
Eupa Ray, Krishna Jadhav, Monika Kadian, Garima Sharma, Kritika Sharma, Agrim Jhilta, Raghuraj Singh, Anil Kumar, Rahul Kumar Verma
Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies. Journal of materials chemistry. B (2024)
Raghuraj Singh, Archna Panghal, Krishna Jadhav, Ashima Thakur, Rahul Kumar Verma, Charan Singh, Manoj Goyal, Jayant Kumar, Ajay G Namdeo
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer's Disease. Molecular neurobiology (2024)
Agrim Jhilta, Krishna Jadhav, Raghuraj Singh, Eupa Ray, Alok Kumar, Amit Kumar Singh, Rahul Kumar Verma
Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression. ACS infectious diseases 10 (8) (2024)
Agrim Jhilta, Krishna Jadhav, Raghuraj Singh, Eupa Ray, Alok Kumar, Amit Kumar Singh, Rahul Kumar Verma
Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression. ACS infectious diseases (2024)
Eknath B Kole, Krishna Jadhav, Shilpa Mandpe, Ashwin Abhang, Rahul K Verma, Jitendra Naik
Recent Developments in Tyrosine Kinase Inhibitor-based Nanotherapeutics for EGFR-resistant Non-small Cell Lung Cancer. Current drug delivery (2024)